Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 20, 2018

DrugPatentWatch Database Preview

LEVOFLOXACIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Levofloxacin patents expire, and when can generic versions of Levofloxacin launch?

Levofloxacin is a drug marketed by Akorn, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Hospira Inc, Mylan Asi, Zydus Pharms Usa Inc, Apotex Inc, Mylan Labs Ltd, Rising Pharms Inc, Watson Labs Teva, Hi Tech Pharma, Cipla Ltd, Dr Reddys Labs Inc, Glenmark Generics, Hetero Labs Ltd V, Jubilant Generics, Lupin, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Sandoz, Teva, Torrent Pharms, Watson Labs Inc, Wockhardt, Fresenius Kabi Usa, Hikma Farmaceutica, and Inforlife. and is included in thirty-seven NDAs.

The generic ingredient in LEVOFLOXACIN is levofloxacin. There are thirty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the levofloxacin profile page.

Summary for LEVOFLOXACIN

US Patents:	0
Applicants:	29
NDAs:	37
Suppliers / Packagers:	62
Bulk Api Vendors:	58
Clinical Trials:	181
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for LEVOFLOXACIN
DailyMed Link:	LEVOFLOXACIN at DailyMed

Drug patent expirations by year for LEVOFLOXACIN

Pharmacology for LEVOFLOXACIN

Ingredient-type	Quinolones
Drug Class	Quinolone Antimicrobial

Medical Subject Heading (MeSH) Categories for LEVOFLOXACIN

Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Cytochrome P-450 CYP1A2 Inhibitors
Topoisomerase II Inhibitors

US Patents and Regulatory Information for LEVOFLOXACIN

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Ltd	LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER	levofloxacin	INJECTABLE;INJECTION	206919-003	Feb 10, 2016	AP	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Lupin	LEVOFLOXACIN	levofloxacin	TABLET;ORAL	078424-002	Jun 20, 2011	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Glenmark Generics	LEVOFLOXACIN	levofloxacin	TABLET;ORAL	200250-001	Jun 20, 2011	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Inforlife	LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER	levofloxacin	INJECTABLE;INJECTION	090343-002	Jul 7, 2011	AP	RX	No	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army

Johnson and Johnson

Daiichi Sankyo

Cipla

McKesson

Boehringer Ingelheim

Harvard Business School

US Department of Justice

QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.